P
Precigen, Inc.
PGEN · NASDAQ · Healthcare · 2.2B
Closing price
$7.81
+2.76% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
113.8×
Enterprise value / EBITDAEV/EBITDA
-10.0×
Free cash flow yieldFCF yield
-3.8%
Return on equityROE
-1198.6%
Operating margin
-1100.8%
Net debt / EBITDAbalance-sheet strength
-0.3×
Interest coverage
-27.6×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.